| Value | ₹29.82 Cr |
|---|---|
| Execution period | 18 months |
NSE filing, NSE: SHEETAL. Summary written from the filing by ALFA Finder's alert engine.
Sheetal Universal Ltd: key numbers
- Share price
- ₹379.75
- Market cap
- ₹454.8 Cr
- Revenue (annual)
- ₹173.8 Cr
- Net profit (annual)
- ₹11.51 Cr
- P/E (TTM)
- 39.5×Sector 27.1×
- Promoter holding
- 66.43%
- FII holding
- 1.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sheetal Universal Ltd
All →Sheetal Universal Other Announcement
Sheetal Universal informed NSE that Reg 27(2) corporate governance reporting is not applicable for Q1 FY27. The filing is a routine non-applicability intimation based on SME Exchange listing.
Sheetal Universal Convertible Warrants
Sheetal Universal allotted 9,00,000 equity shares upon conversion of warrants at ₹210 each, aggregating to ₹18.90 Crore. The warrants were held by promoters and non-promoters.
- Value
- ₹18.90 Cr
Sheetal Universal Annual General Meeting
Sheetal Universal Limited held its 11th Annual General Meeting on September 30, 2026. Shareholders considered and approved financial statements and director re-appointments.
Sheetal Universal Capital Structure Change
Sheetal Universal Limited received trading approval from NSE for 2,61,000 equity shares. These shares were allotted following the conversion of warrants issued on a preferential basis.
Sheetal Universal Capital Structure Change
Sheetal Universal Limited received Rs. 5.57 Crore as a further tranche of consideration for previously allotted convertible warrants from a promoter category allottee.
- Value
- ₹5.57 Cr
Sheetal Universal Capital Structure Change
Sheetal Universal Limited received a Rs. 4.23 Crore tranche from a promoter for 14,20,000 convertible warrants. This payment represents further consideration for warrants previously allotted at Rs. 210 each.
- Value
- ₹4.23 Cr
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr
MosChip Technologies Fund Raise of ₹112.2 Cr
MosChip Technologies approved a preferential issue of 50,50,686 equity shares at Rs.222 to 69 investors, raising about Rs.112.19 Crore. The board approval covers the fund raise, with an AGM/postal ballot dated 25 November 2026.
- Value
- ₹112.2 Cr
Cholamandalam Investment & Finance Company Fund Raise
Cholamandalam's board approved a Qualified Institutions Placement fund raise on 28 October 2026, subject to shareholder postal ballot. The quantum, price and terms remain undetermined.
Bodhi Tree Multimedia Fund Raise
Bodhi Tree Multimedia's EOGM on October 28, 2026, sought approval for a qualified institutions placement. The filing states no issue size.